Dennis Mulroy
CIK: 0001276840
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (24 total)
- May 1, 2026ARCT
Arcturus Therapeutics Holdings Inc.
Award(A)DirectEmployee Stock Option (right to buy)
100K shares- - Jan 8, 2026ANAB
ANAPTYSBIO, INC
Sale(S)Direct2.5K shares at avg. $44.71$112K - Jan 7, 2026ANAB
ANAPTYSBIO, INC
Exercise(M)Direct6.7K shares- - Jan 7, 2026ANAB
ANAPTYSBIO, INC
Sale(S)Direct1.9K shares at avg. $45.11$86K - Jan 6, 2026ANAB
ANAPTYSBIO, INC
Award(A)DirectRestricted Stock Unit
21.4K shares- - Jan 6, 2026ANAB
ANAPTYSBIO, INC
Exercise(M)Direct5.2K shares- - Jan 6, 2026ANAB
ANAPTYSBIO, INC
Award(A)DirectStock Option (right to buy)
29K shares- - Jan 5, 2026ANAB
ANAPTYSBIO, INC
Sale(S)Direct3.4K shares at avg. $43.26$145K - Jan 3, 2026ANAB
ANAPTYSBIO, INC
Exercise(M)Direct8.3K shares- - Dec 22, 2025ANAB
ANAPTYSBIO, INC
Exercise(M)Direct10K shares at avg. $20.16$202K - Dec 22, 2025ANAB
ANAPTYSBIO, INC
Sale(S)Direct10K shares at avg. $50.00$500K - Dec 16, 2025ANAB
ANAPTYSBIO, INC
Sale(S)Direct6.4K shares at avg. $45.21$288K - Dec 16, 2025ANAB
ANAPTYSBIO, INC
Exercise(M)Direct10K shares at avg. $20.16$202K - Dec 16, 2025ANAB
ANAPTYSBIO, INC
Sale(S)Direct9.4K shares at avg. $44.62$418K - Jan 7, 2025ANAB
ANAPTYSBIO, INC
Award(A)DirectStock Option (right to buy)
76.4K shares- - Jan 7, 2025ANAB
ANAPTYSBIO, INC
Award(A)DirectRestricted Stock Unit
26.8K shares- - Jan 6, 2025ANAB
ANAPTYSBIO, INC
Tax Payment(F)Direct2.1K shares at avg. $15.30$31K - Jan 6, 2025ANAB
ANAPTYSBIO, INC
Exercise(M)Direct5.2K shares- - Jan 3, 2025ANAB
ANAPTYSBIO, INC
Tax Payment(F)Direct3.4K shares at avg. $14.60$50K - Jan 3, 2025ANAB
ANAPTYSBIO, INC
Exercise(M)Direct8.3K shares- - Sep 16, 2024ANAB
ANAPTYSBIO, INC
Exercise(M)Direct10K shares at avg. $20.16$202K - Sep 16, 2024ANAB
ANAPTYSBIO, INC
Sale(S)Direct2.2K shares at avg. $38.93$86K - Sep 16, 2024ANAB
ANAPTYSBIO, INC
Sale(S)Direct10K shares at avg. $40.13$401K - Sep 14, 2024ANAB
ANAPTYSBIO, INC
Exercise(M)Direct6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 1, 2026 |  ARCT Arcturus Therapeutics Holdings Inc. | Award(A) Employee Stock Option (right to buy) | 100,000 | - | - | Direct |
| Jan 8, 2026 |  ANAB ANAPTYSBIO, INC | Sale(S) | 2,515 | $44.71 | $112,446 | Direct |
| Jan 7, 2026 | ANAB ANAPTYSBIO, INC | Exercise(M) | 6,700 | - | $0 | Direct |
| Jan 7, 2026 | ANAB ANAPTYSBIO, INC | Sale(S) | 1,908 | $45.11 | $86,070 | Direct |
| Jan 6, 2026 | ANAB ANAPTYSBIO, INC | Award(A) Restricted Stock Unit | 21,400 | - | - | Direct |
| Jan 6, 2026 | ANAB ANAPTYSBIO, INC | Exercise(M) | 5,245 | - | $0 | Direct |
| Jan 6, 2026 | ANAB ANAPTYSBIO, INC | Award(A) Stock Option (right to buy) | 29,000 | - | - | Direct |
| Jan 5, 2026 | ANAB ANAPTYSBIO, INC | Sale(S) | 3,363 | $43.26 | $145,483 | Direct |
| Jan 3, 2026 | ANAB ANAPTYSBIO, INC | Exercise(M) | 8,292 | - | $0 | Direct |
| Dec 22, 2025 | ANAB ANAPTYSBIO, INC | Exercise(M) | 10,000 | $20.16 | $201,600 | Direct |
| Dec 22, 2025 | ANAB ANAPTYSBIO, INC | Sale(S) | 10,000 | $50.00 | $500,000 | Direct |
| Dec 16, 2025 | ANAB ANAPTYSBIO, INC | Sale(S) | 6,360 | $45.21 | $287,511 | Direct |
| Dec 16, 2025 | ANAB ANAPTYSBIO, INC | Exercise(M) | 10,000 | $20.16 | $201,600 | Direct |
| Dec 16, 2025 | ANAB ANAPTYSBIO, INC | Sale(S) | 9,365 | $44.62 | $417,821 | Direct |
| Jan 7, 2025 | ANAB ANAPTYSBIO, INC | Award(A) Stock Option (right to buy) | 76,400 | - | - | Direct |
| Jan 7, 2025 | ANAB ANAPTYSBIO, INC | Award(A) Restricted Stock Unit | 26,800 | - | - | Direct |
| Jan 6, 2025 | ANAB ANAPTYSBIO, INC | Tax Payment(F) | 2,054 | $15.30 | $31,426 | Direct |
| Jan 6, 2025 | ANAB ANAPTYSBIO, INC | Exercise(M) | 5,245 | - | $0 | Direct |
| Jan 3, 2025 | ANAB ANAPTYSBIO, INC | Tax Payment(F) | 3,407 | $14.60 | $49,742 | Direct |
| Jan 3, 2025 | ANAB ANAPTYSBIO, INC | Exercise(M) | 8,293 | - | $0 | Direct |
| Sep 16, 2024 | ANAB ANAPTYSBIO, INC | Exercise(M) | 10,000 | $20.16 | $201,600 | Direct |
| Sep 16, 2024 | ANAB ANAPTYSBIO, INC | Sale(S) | 2,220 | $38.93 | $86,425 | Direct |
| Sep 16, 2024 | ANAB ANAPTYSBIO, INC | Sale(S) | 10,000 | $40.13 | $401,300 | Direct |
| Sep 14, 2024 | ANAB ANAPTYSBIO, INC | Exercise(M) | 6,000 | - | $0 | Direct |
1-24 of 24 transactions
About MULROY DENNIS
MULROY DENNIS (SEC CIK 0001276840) files insider reports with the SEC as Chief Financial Officer of Arcturus Therapeutics Holdings Inc. (ARCT) and CHIEF FINANCIAL OFFICER of ANAPTYSBIO, INC (ANAB).
Signal8 holds 9 ownership filings by MULROY DENNIS (1 Form 3, 8 Form 4), filed between Sep 17, 2024 and May 7, 2026. Those filings report 24 transactions, from Sep 14, 2024 to May 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on MULROY DENNIS's filings is in SAN DIEGO, CA.
Recent filings by MULROY DENNIS
- May 1, 2026: Grant or award of ARCT derivative securities (Form 4, code A).
- Jan 8, 2026: Open-market sale of ANAB shares (Form 4, code S).
- Jan 7, 2026: Option exercise of ANAB shares (Form 4, code M).
- Jan 7, 2026: Open-market sale of ANAB shares (Form 4, code S).
- Jan 6, 2026: Grant or award of ANAB derivative securities (Form 4, code A).
Other insiders filing for Arcturus Therapeutics Holdings Inc. (ARCT)
- HOLMES EDWARD W, Director
- FARRELL PETER C, Director
- BARLOW JAMES F, Director
- Markels John, Director
- Slaoui Moncef, Director
- Marquet Magda, Director